Liquid Biopsy Market Report 2020-2030

Summary

Please note: this report is accessed through a password system. Single user (non-printable) and departmental licenses expires after 12 month period.

Liquid Biopsy Market Report 2020-2030: Forecasts by Product (Instruments, Kits & Reagents, Services), by Sample Type (Blood Samples, Urine Samples, Others), by Biomarker (Circulating Tumour Cell (CTC), Circulating Tumour DNA (ctDNA), Exosomes, Others), by Cancer Type (Breast Cancer, Colorectal Cancer, Liver Cancer, Lung Cancer, Prostate Cancer, Others), by End-user (Hospitals, Diagnostic Laboratories, Academic Institutions, Cancer Research Centres), by Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa), Plus Analysis of Leading Companies

The main drivers for the growth include technological advancements such as development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies. Moreover, rising number of pre-screening programs for cancer detection using liquid biopsy are expected to provide new market opportunities to the key players in the near future.

This this report covers the global liquid biopsy market, including analysis of the market by product type, biomarker type, sample type, cancer type, end user and national markets for liquid biopsy products. We aim to provide a comprehensive and critical analysis of the market, assessing the market’s potential from a variety of viewpoints. We examine the opportunities and challenges that exist within the market, as well as the major commercial trends. We also analyses the market prospects for different segments and provide an overview of the research and development in this sector.

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

Liquid Biopsy Market Dynamics:
• Increasing Prevalence of Cancer
• Rising Ageing Population
• Rising Demand for Safe and Minimally Invasive Procedures
• Advantages of Liquid Biopsy and Cost Effectiveness
• Disparity in Reimbursements
• Strict Regulatory Environment
• Increasing involvement of global market players through collaborations/agreements
• Progress in the development of liquid biopsy tests

Liquid Biopsy Market Segmentation 2020-2030:

Segmentation by Product, 2020 – 2030 (USD Million)
• Instruments
• Kits & Reagents
• Services

Segmentation by Sample Type, 2020 – 2030 (USD Million)
• Blood Samples
• Urine Samples
• Others

Segmentation by Biomarker, 2020 – 2030 (USD Million)
• Circulating Tumour Cell (CTC)
• Circulating Tumour DNA (ctDNA)
• Exosomes
• Others

Segmentation by Cancer Type, 2020 – 2030 (USD Million)
• Breast Cancer
• Colorectal Cancer
• Liver Cancer
• Lung Cancer
• Prostate Cancer
• Others

Segmentation by End-User, 2020 – 2030 (USD Million)
• Hospitals
• Diagnostic Laboratories
• Academic Institutions
• Cancer Research Centres

Segmentation by Geography, 2020 – 2030 (USD Million)

• North America
• U.S.
• Canada

• Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Poland
• Rest of Europe

• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Southeast Asia
• Rest of Asia Pacific

• Latin America
• Brazil
• Argentina
• Venezuela
• Mexico
• Rest of Latin America

• Middle East & Africa
• Turkey
• UAE
• South Africa
• Saudi Arabia
• Rest of Middle East & Africa

Liquid Biopsy Market: Top 10 Companies
• Menarini Silicon Biosystems, Inc.
• MDxHealth SA
• Biocept, Inc.
• Trovagene, Inc.
• Sysmex Inostics GmbH
• F. Hoffmann-La Roche AG
• Bio-Rad Laboratories, Inc.
• Guardant Health, Inc.
• Illumina, Inc.
• Myriad Genetics, Inc.

Methodology

Our market research methodology is designed to provide the clients with comprehensive and accurate information on various industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data analysis etc.

The data is gathered from a wide range of sources, including industry reports, government statistics, and company financials. This data is then analyzed and cross-referenced to ensure its accuracy and reliability. Next, primary interviews are conducted with industry experts and key stakeholders to gather their insights and perspectives on the market. This information is then combined with the data collected to provide a complete picture of the market. Macro-economic factor analysis is also carried out to understand the impact of external factors on the market. Finally, country-level data analysis is performed to understand the market dynamics in specific regions and countries.

Reportlinker's market research methodology is designed to provide clients with a clear understanding of the market, its trends, and its future potential.

Related Topics

• Genetic Testing
• Biopsy
• Life Sciences
• Biotechnology
• Medical Biotechnology
• Biotech Diagnostics
• Healthcare
• Diagnostics

Related Reports

• Smart Biopsy Devices Market Research Report by Application, End-User, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
  $ 3949

  January 2023 234 pages

• Global Biopsy Devices Industry
  $ 4950

  March 2023 196 pages

• Global Breast Lesion Localization Industry
  $ 4950

  March 2023 193 pages

More Reports

• Genetic Testing - Germany
• Genetic Testing - Italy
• Genetic Testing - Spain
• Genetic Testing - France
• Genetic Testing - United Kingdom
• Genetic Testing - Japan
• Genetic Testing - Scandinavia
• Genetic Testing - Baltics
• Genetic Testing - Switzerland
• Genetic Testing - Ukraine